Introduction to Finance 


Jurriaan Dekkers | Chief Financial Officer, ProQR Therapeutics

Jurriaan joined ProQR in 2022 as Chief Financial Officer where he leads the finance function. He brings to the role more than 20 years of experience in finance, management and leadership roles in biopharma and healthcare companies, as well as in audit and consulting services. Prior to joining ProQR he most recently served as CFO of AstraZeneca in the Netherlands and CEO of Acerta Pharma (part of the AstraZeneca Group). Previously Jurriaan held various global and European finance roles at amongst others DaVita Medical Group, a US-listed international healthcare provider, and started his career at PwC.  He is a Supervisory Board member at ‘Stichting Kinderpostzegels’ in the Netherlands. Jurriaan holds a MSc. in Economics from the Erasmus University Rotterdam, the Netherlands (2001) and is a Certified Public Auditor (Register Accountant, RA) graduate from the Erasmus University Rotterdam (2004).



ProQR Therapeutics

We are ProQR, a biotechnology company dedicated to changing lives by developing RNA therapies for severe rare and common diseases. We focus on advancing our proprietary Axiomer™ RNA-editing platform technology. ProQR has offices in Leiden, the Netherlands and Cambridge, Massachusetts, USA.

From the day our company was founded in 2012, our mission has been to help people living with rare diseases that currently have no treatment options. This remains an important focus of our company today.

In order to achieve our goals, ProQR strives to integrate the patient voice into our decision-making throughout the drug development process as we believe that a patient-focused strategy is crucial to our success.

Powered by:
BCF Courses BV   

    Connect with us                  

Join BioBusiness Summer School

Privacy Policy
Terms & Conditions 

Chamber of Commerce: 75874415
         
  
  
  
                                    

        REGISTER NOW
    

© Copyright 2020 by BCF Courses